President and CEO of Denali Therapeutics Inc. (NASDAQ:DNLI), Watts Ryan J., sells 5,112 shares worth $377,211
According to Denali Therapeutics Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 10 07:40 PM, company President and CEO, Watts Ryan J. disclosed selling 5,112 shares at a cost of $73.79. At the time of this transaction (Feb 09), this trade was worth $377,211 in total. As of Feb 09, Watts Ryan J. now owns 2,313,853 shares in total worth about $169,975,641.38.
For the last few recent trades made by Denali Therapeutics Inc. (NASDAQ:DNLI) President and CEO, Watts Ryan J., we have the following information:
- SEC Form 4 filing: Feb 01: Sold 18,334 shares at the rate of $68.44 per share. Total worth of this trade was $1,254,819. Total number of shares owned as of Feb 01 were 2,304,649
- SEC Form 4 filing: Jan 04: Sold 88,334 shares at the rate of $74.96 per share. Total worth of this trade was $6,621,782. Total number of shares owned as of Jan 04 were 2,322,978
- SEC Form 4 filing: Mar 30: Sold 4,807 shares at the rate of $19.48 per share. Total worth of this trade was $93,640. Total number of shares owned as of Mar 30 were 22,013
Posted by
George Daniels
on Wednesday February 10 2021, 11:08 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
